Hasil Pencarian - Martin Oft

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    IL-2 based cancer immunotherapies: an evolving paradigm

    IL-2 based cancer immunotherapies: an evolving paradigm oleh Sushama Rokade, Anita Mehta Damani, Martin Oft, Jan Emmerich

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Interleukin 10-Mediated Response and Correlated Anemia in a Patient with Advanced Non-Small Cell Lung Carcinoma

    Interleukin 10-Mediated Response and Correlated Anemia in a Patient with Advanced Non-Small Cell Lung Carcinoma oleh Khalil Choucair, Jesse D. Kelso, Joseph R. Duff, Christine S. Cassidy, Mary T. Albrethsen, Mushtaq Ashraf, Cherian Verghese, Martin Oft, F. Charles Brunicardi, Lance Dworkin, John Nemunaitis

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia.

    PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia. oleh Ivan H Chan, Dennis Van Hoof, Marina Abramova, Melissa Bilardello, Elliot Mar, Brett Jorgensen, Scott McCauley, Harminder Bal, Martin Oft, Peter Van Vlasselaer, John B Mumm

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    228 Engineered human IL-2/IL-2Rß orthogonal pairs selectively enhance anti-GPC3 CAR T cells in vivo to drive complete responses in solid epithelial tumor models

    228 Engineered human IL-2/IL-2Rß orthogonal pairs selectively enhance anti-GPC3 CAR T cells in vivo to drive complete responses in solid epithelial tumor models oleh Martin Oft, Mohammed Ali, Ryan Burgess, Michele Bauer, Deepti Rokkam, Navneet Ratti, Sandro Vivona, Patrick Lupardus, Paul-Joseph Aspuria, Marie Semana, Ivan Cheng, Mahalaksmi Ramadass, Henry Rosas, George Zheng

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    1053 Preclinical pharmacodynamic characterization of STK-026: a novel IL-12 partial agonist for cancer with maintained CD8 T cell activity, reduced NK-mediated toxicity and an improved therapeutic window

    1053 Preclinical pharmacodynamic characterization of STK-026: a novel IL-12 partial agonist for cancer with maintained CD8 T cell activity, reduced NK-mediated toxicity and an impr... oleh Martin Oft, Michael Totagrande, Luis Zuniga, David B Rosen, Priyanka Balasubrahmanyam, Zhenya Koliesnik, Ryan Burgess, Kim Q Tran, Michele Bauer, Bharghavi Jayaraman, Cindy Buffone, Jan Emmerich, Deepti Chaturvedi, Deepti Rokkam, Rene De Waal Malefyt, Heiko Greb, Navneet Ratti, Sandro Vivona, Robert Kastelein, Patrick Lupardus

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: